Quantbot Technologies LP Athira Pharma, Inc. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$2.26 - $4.22 $3,615 - $6,752	1,600 New	1,600 $4,000
Q1 2022 May 16, 2022	SELL	$8.96 - $13.51 $15,232 - $22,967	-1,700 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$9.17 - $16.39 $21,091 - $37,697	-2,300 Reduced 57.5%	1,700 $22,000
Q3 2021 Nov 09, 2021	BUY	$9.15 - $11.09 $36,600 - $44,360	4,000 New	4,000 $37,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $21.9M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.